E-Clinical Solutions Market Is Growing At A High Cagr By 2025 According To A New Research Report

Pune, May 16, 2019 (Issuewire.com) – Global E-Clinical Solutions Industry was valued approximately USD 3.5 billion in 2016, is anticipated to grow at a CAGR of 15.39% by 2025.

More on StockNewDesk:

Industry growth is attributed to the rising government funding and R&D investments from pharma-biotech companies. Moreover, clinical research studies incur a higher cost and are highly regulated, thus there is a rapid increase in the adoption of cost-effective e clinical solution. Additionally, with the advent of big data and healthcare IT, the global healthcare industry is moving towards centralization of data for faster and better execution of healthcare, anywhere across the globe. The E-Clinical Solutions will enable the effective planning, tracking and execution of the healthcare database across different countries.

Get Free Sample [email protected] https://www.globalreportsstore.com/request-sample/11410

The major market players in E-Clinical Solutions Industry are Bio-Optronics, Inc., CRF Health, Datatrak International, Inc., Eclinical Solutions, LLC., ERT Clinical, Maxisit Inc., Medidata Solutions, Inc., Merge Healthcare Incorporated, Systems, Inc., Oracle Corporation, Parexel International Corporations, and others. On the basis of delivery mode, currently, the Industry is dominated by web hosted delivery model. The web-hosted delivery model aids faster and easy accessibility of data and incurs lower cost than on-premise delivery. However, in coming years, cloud-hosted models are expected to grow at the highest CAGR. The Industry growth is primarily driven by the ability of the cloud to flexibly integrate with multiple platforms and the pay as you go model. 

In 2016, North America dominates the global E-Clinical Solutions Industry with more than 35% revenue share. The Industry growth is driven by the presence of a large number of pharmaceutical and biotechnology firms in the region. Moreover, there is a significant rise in the number of clinical trials in the region due to increasing support from government funds. However, during the forecast period, Asia Pacific Industry is expected to grow at an accelerating rate. Due to less stringent regulations in many Asian countries, the biotechnology and pharmaceuticals companies across the world are outsourcing clinical trials to the developing countries in the Asia Pacific. 

Inquiry Before [email protected] https://www.globalreportsstore.com/send-an-enquiry/11410

By Product:
Electronic Data Capture and Clinical Data Management Systems
Clinical Trial Management Systems
Clinical Analytics Platforms 
Randomization and Trial Supply Management 
Clinical Data Integration Platforms
Electronic Clinical Outcome Assessment Solutions
Safety Solutions
Electronic Trial Master File Systems
Regulatory Information Management Solutions
Other E-Clinical Solutions

Delivery Mode:
Web-Hosted Solutions
On-Premise Solutions
Cloud-based(SaaS) Solutions

End User:
E-Clinical Solutions Industry, Sub Segment Analysis
Contract Research Organizations 
Medical Device Manufacturers 
Hospitals
Academic Research Institutes

Directly Purchase This Report at USD 3550: https://www.globalreportsstore.com/checkout/11410

More on StockNewDesk:

By Region
North America
USA
Canada
Europe
Germany
U.K.
France
Italy
Rest of Europe
APAC
China
India
Japan
Rest of Asia-Pacific
RoW
Latin America
Middle East & Africa

Media Contact

Global RS

[email protected]

https://www.globalreportsstore.com/

Source :Global Reports Store

This article was originally published by IssueWire. Read the original article here.

Latest on StockNewDesk:

Login

Lost your password?